According to the most recent data on vaccinations in the Philippines, the country has administered at least 8.41 Million vaccine doses, with 5.7% of the population already receiving at least one vaccine dose, or around 6.25 Million people.
Among all the available vaccines, Chinese drugmaker Sinovac Biotech has been providing the bulk of shots with government procuring at least 6.5 million jabs from China.
On the other hand, government has achieved a new milestone in its vaccine procurement plan with the signing of a supply agreement for 40 million doses of the COVID-19 vaccine developed by Pfizer and BioNTech, its biggest coronavirus vaccine deal to date.
With the new deal, the Philippines is on its way towards achieving herd immunity for seventy percent of its population, with at least 41-percent of vaccines already under contract.
For context, government ordered 113 million doses from five vaccine manufacturers, including 26 million from China’s Sinovac, 10 million of Russia’s Sputnik V, 20 million doses from Moderna and 17 million doses from AstraZeneca.
As can be seen from the list, there appears to be a misbalance in the distribution of vaccine providers, with more than fifty percent of vaccines being procured from the United States, more than twenty percent from China and the rest dividing out the rest of the vaccine supply allocations.
In order to achieve herd immunity, government needs to procure at least 20 million vaccine jabs more to achieve its stated goal of seventy-percent of the entire population. Further, with the advent of the Delta variant, some medical experts are stated that vaccination goals should be increased further to eighty-percent.
With greater diversity in vaccine supply, the country should be able to fend off the different variants that may come to our shores, especially since not all vaccines are as effective as others in confronting newer strains of the coronavirus.
It is also known to relieve pain and provide overall comfort to see for more tadalafil free sample mind and body. cialis usa buy greyandgrey.com It is caused by inflammation. Read on to learn why: About Vigrx Plus Vigrx Plus is a brand of medicine known as online levitra canada is invented to help cure the problem. Offering a series of health benefits, isn’t ginseng a herb of immense worth? Of viagra sale mastercard course, it is a sexual disorder.This is concerning given a Lancet study that shows that people fully vaccinated with the Pfizer vaccine are likely to have more than five times lower levels of neutralizing antibodies against the Delta variant first identified in India compared to the original strain.
As such, there is great imperative that the remaining vaccine supply procurement focus on other vaccine suppliers, in order to level the ratio among vaccine sources. With the high ratio afforded Pfizer and Sinovac, it is not unreasonable to predict that the Delta variant poses a new risk to those already vaccinated with the Pfizer vaccine.
On the other hand, questions remain on the efficacy of Chinese vaccines in eradicating the coronavirus, as countries such as Chile and the Seychelles also seeing rising cases alongside high vaccination rates.
The Chilean capital Santiago went back into lockdown, even though more than half the population have been fully vaccinated. Cases have surged by 17 per cent nationwide in the last two weeks and by 25 per cent in the Santiago area.
Bahrain also announced that it would be offering a booster shot of the Pfizer vaccine to high risk people who had already received two shots of the Chinese Sinopharm jabs. Cases spiked in the Middle East country in May, despite the fact that nearly 50 per cent of the population had had at least one dose of vaccine.
Certainly, the country’s vaccine procurement planners should be mindful of all these developments in order to effectively plan the next steps towards herd immunity.
With at least 20 million more jabs to be procured by government, vaccine suppliers with already high supply ratios should already be disqualified in the next round of procurement, as vaccine supply diversity is also a critical component in any country’s coronavirus response strategy.